Onc Now: Episode 25: The Changing Landscape of Breast Cancer Care

Tolaney focuses on advancing breast cancer treatment through innovative clinical research. She has been instrumental in developing novel therapies and leading key clinical trials, particularly for early-stage HER2-positive breast cancer.     Timestamps   00:09 – Introduction  01:12 – What is HER2-positive breast cancer?  03:00 – Key trials Tolaney has led  07:16 – Antibody-drug conjugates  12:00 - Breast Oncology Guidelines  14:51 – Treatment optimisation   18:27 – Equity in healthcare  21:10 – Mentoring the next generation of oncologists  22:52 – Tolaney's wishes for healthcare